Literature DB >> 25720621

Dual Antiplatelet Therapy Duration Following Coronary Stenting. [Corrected].

Robert W Yeh1, Laura Mauri2, Dean J Kereiakes3.   

Abstract

Entities:  

Keywords:  drug-eluting stent(s); percutaneous coronary angioplasty

Mesh：

Substances：

Year:  2015        PMID： 25720621      PMCID： PMC4689133          DOI： 10.1016/j.jacc.2015.01.004

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  12 in total

1.  Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.

Authors:  Laura Mauri; Dean J Kereiakes; Robert W Yeh; Priscilla Driscoll-Shempp; Donald E Cutlip; P Gabriel Steg; Sharon-Lise T Normand; Eugene Braunwald; Stephen D Wiviott; David J Cohen; David R Holmes; Mitchell W Krucoff; James Hermiller; Harold L Dauerman; Daniel I Simon; David E Kandzari; Kirk N Garratt; David P Lee; Thomas K Pow; Peter Ver Lee; Michael J Rinaldi; Joseph M Massaro
Journal:  N Engl J Med       Date:  2014-11-16       Impact factor: 91.245

Review 2.  Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.

Authors:  Tullio Palmerini; Giuseppe Biondi-Zoccai; Diego Della Riva; Christoph Stettler; Diego Sangiorgi; Fabrizio D'Ascenzo; Takeshi Kimura; Carlo Briguori; Manel Sabatè; Hyo-Soo Kim; Antoinette De Waha; Elvin Kedhi; Pieter C Smits; Christoph Kaiser; Gennaro Sardella; Antonino Marullo; Ajay J Kirtane; Martin B Leon; Gregg W Stone
Journal:  Lancet       Date:  2012-03-23       Impact factor: 79.321

3.  2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

Authors:  Glenn N Levine; Eric R Bates; James C Blankenship; Steven R Bailey; John A Bittl; Bojan Cercek; Charles E Chambers; Stephen G Ellis; Robert A Guyton; Steven M Hollenberg; Umesh N Khot; Richard A Lange; Laura Mauri; Roxana Mehran; Issam D Moussa; Debabrata Mukherjee; Brahmajee K Nallamothu; Henry H Ting
Journal:  Circulation       Date:  2011-11-07       Impact factor: 29.690

4.  Duration of dual antiplatelet therapy after implantation of drug-eluting stents.

Authors:  Seung-Jung Park; Duk-Woo Park; Young-Hak Kim; Soo-Jin Kang; Seung-Whan Lee; Cheol Whan Lee; Ki-Hoon Han; Seong-Wook Park; Sung-Cheol Yun; Sang-Gon Lee; Seung-Woon Rha; In-Whan Seong; Myung-Ho Jeong; Seung-Ho Hur; Nae-Hee Lee; Junghan Yoon; Joo-Young Yang; Bong-Ki Lee; Young-Jin Choi; Wook-Sung Chung; Do-Sun Lim; Sang-Sig Cheong; Kee-Sik Kim; Jei Keon Chae; Deuk-Young Nah; Doo-Soo Jeon; Ki Bae Seung; Jae-Sik Jang; Hun Sik Park; Keun Lee
Journal:  N Engl J Med       Date:  2010-03-15       Impact factor: 91.245

5.  Balancing the risks of bleeding and stent thrombosis: a decision analytic model to compare durations of dual antiplatelet therapy after drug-eluting stents.

Authors:  Pallav Garg; Benjamin Z Galper; David J Cohen; Robert W Yeh; Laura Mauri
Journal:  Am Heart J       Date:  2014-11-10       Impact factor: 4.749

6.  Discrepancies between meta-analyses and subsequent large randomized, controlled trials.

Authors:  J LeLorier; G Grégoire; A Benhaddad; J Lapierre; F Derderian
Journal:  N Engl J Med       Date:  1997-08-21       Impact factor: 91.245

7.  Dual antiplatelet therapy after drug-eluting stents--how long to treat?

Authors:  Antonio Colombo; Alaide Chieffo
Journal:  N Engl J Med       Date:  2014-11-16       Impact factor: 91.245

8.  Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial.

Authors:  Antonio Colombo; Alaide Chieffo; Arian Frasheri; Roberto Garbo; Monica Masotti-Centol; Neus Salvatella; Juan Francisco Oteo Dominguez; Luigi Steffanon; Giuseppe Tarantini; Patrizia Presbitero; Alberto Menozzi; Edoardo Pucci; Josepa Mauri; Bruno Mario Cesana; Gennaro Giustino; Gennaro Sardella
Journal:  J Am Coll Cardiol       Date:  2014-09-15       Impact factor: 24.094

9.  6- versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trial.

Authors:  Martine Gilard; Paul Barragan; Arif A L Noryani; Hussam A Noor; Talib Majwal; Thomas Hovasse; Philippe Castellant; Michel Schneeberger; Luc Maillard; Erwan Bressolette; Jaroslaw Wojcik; Nicolas Delarche; Didier Blanchard; Bernard Jouve; Olivier Ormezzano; Franck Paganelli; Gilles Levy; Joël Sainsous; Didier Carrie; Alain Furber; Jacques Berland; Oliver Darremont; Hervé Le Breton; Anne Lyuycx-Bore; Antoine Gommeaux; Claude Cassat; Alain Kermarrec; Pierre Cazaux; Philippe Druelles; Raphael Dauphin; Jean Armengaud; Patrick Dupouy; Didier Champagnac; Patrick Ohlmann; Knut Endresen; Hakim Benamer; Robert Gabor Kiss; Imre Ungi; Jacques Boschat; Marie-Claude Morice
Journal:  J Am Coll Cardiol       Date:  2014-11-16       Impact factor: 24.094

10.  Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study.

Authors:  Hyeon-Cheol Gwon; Joo-Yong Hahn; Kyung Woo Park; Young Bin Song; In-Ho Chae; Do-Sun Lim; Kyoo-Rok Han; Jin-Ho Choi; Seung-Hyuk Choi; Hyun-Jae Kang; Bon-Kwon Koo; Taehoon Ahn; Jung-Han Yoon; Myung-Ho Jeong; Taek-Jong Hong; Woo-Young Chung; Young-Jin Choi; Seung-Ho Hur; Hyuck-Moon Kwon; Dong-Woon Jeon; Byung-Ok Kim; Si-Hoon Park; Nam-Ho Lee; Hui-Kyung Jeon; Yangsoo Jang; Hyo-Soo Kim
Journal:  Circulation       Date:  2011-12-16       Impact factor: 29.690
View more
  1 in total

1.  The Impact of Renal Dysfunction on the Long Term Clinical Outcomes of Diabetic Patients Undergoing Percutaneous Coronary Intervention in the Drug-Eluting Stent Era.

Authors:  Ki Hong Choi; Jeong Hoon Yang; Ji Hwan Kim; Young Bin Song; Joo-Yong Hahn; Jin-Ho Choi; Hyeon-Cheol Gwon; Sang Hoon Lee; Seung-Hyuk Choi
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.